BioTrak Therapeutics

United States
Santa Maria, California, United States

Company profile

BioTrak Therapeutics company profile

BioTrak is digital therapeutics platform company with smartphone products which deliver evidence-based, preventative treatment of stress-related disorders such as migraine, multiple sclerosis, depression, chronic pain, and anxiety. The first of a series of products is Ease: Headache and Migraine™, which was launched Q1’ 19. Three (3) billion people worldwide suffer from severe tension-type headaches and migraine. Ease, which delivers clinically-tested behavioral interventions on a mobile platform, is superior in clinical effectiveness, safety, cost, and convenience compared to the most advanced migraine drugs. Ease is positioned to be used either alone or adjunctively with conventional drug therapies. Ease: Headache & Migraine™ is digital therapeutic app that delivers clinically-proven, effective behavioral therapy. Ease has been shown to be as effective as in-office treatment, resulting in 60% reduction in headache frequency and disability. Ease is a brand new approach to addressing the severely unmet need for a scalable, affordable, safe and effective treatment option for the estimated 3 billion people who suffer from tension headache and migraine worldwide.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2016-01-01, Month

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Non Equity Assistance / 2018-05-23
Investors
1
Founders
5
Articles
10

Founders and investors

Founders

Adam KirellEric LeeErik LillydahlRobert BratzlerWilliam "Pete" Lillydahl

Investors

MassChallenge